Suppr超能文献

减肥药和泻药的使用与控制体重,预示着女性青少年和年轻成年人在未来 5 年内首次被诊断为饮食失调的可能性。

Diet pill and laxative use for weight control predicts first-time receipt of an eating disorder diagnosis within the next 5 years among female adolescents and young adults.

机构信息

Sanford Center for Biobehavioral Research, Fargo, North Dakota, USA.

Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

出版信息

Int J Eat Disord. 2021 Jul;54(7):1289-1294. doi: 10.1002/eat.23531. Epub 2021 May 5.

Abstract

OBJECTIVE

To replicate findings from a prior study which identified prospective associations between use of products for weight control and subsequent receipt of a first-time eating disorder (ED) diagnosis among female adolescents and young adults.

METHOD

Data from a prospective cohort study, Project EAT (Eating and Activity in Teens and Young Adults), were used to examine prospective associations between self-reported past-year diet pill and laxative use for weight control and self-reported receipt of an ED diagnosis among females without prior receipt of an ED diagnosis (N = 1,015). Participants were followed from early/middle adolescence (EAT-I; M  = 14.9 years) into late adolescence/emerging adulthood (EAT-II; M  = 19.5 years) and young adulthood (EAT-III; M  = 24.8 years).

RESULTS

First-time receipt of an ED diagnosis was reported by 2.4% of participants at EAT-II and 4.0% at EAT-III. After adjusting for demographics and weight status, participants using diet pills (risk ratio [RR] = 3.58, 95% confidence interval [CI]: 1.96-6.54) and laxatives (RR = 2.77, 95% CI: 1.01-7.64) had greater risk of receiving a first-time ED diagnosis within 5 years than those not using these products.

DISCUSSION

The present study replicated prior findings, providing further evidence for a prospective link between use of products for weight control and subsequent receipt of an ED diagnosis.

摘要

目的

复制先前的一项研究结果,该研究确定了女性青少年和年轻成年人使用体重控制产品与随后首次被诊断为饮食失调症(ED)之间存在前瞻性关联。

方法

本研究使用了一项前瞻性队列研究项目 EAT(青少年和年轻成年人的饮食和活动)的数据,调查了过去一年中自我报告的减肥药和泻药用于体重控制的使用情况与之前未被诊断为 ED 的女性中自我报告的 ED 诊断之间的前瞻性关联(N=1015)。参与者从青少年早期/中期(EAT-I;M=14.9 岁)到青少年晚期/成年早期(EAT-II;M=19.5 岁)和成年早期(EAT-III;M=24.8 岁)进行随访。

结果

在 EAT-II 和 EAT-III 中,分别有 2.4%和 4.0%的参与者首次报告被诊断为 ED。在调整人口统计学和体重状况后,使用减肥药(风险比 [RR]=3.58,95%置信区间 [CI]:1.96-6.54)和泻药(RR=2.77,95% CI:1.01-7.64)的参与者在 5 年内被诊断为 ED 的风险高于未使用这些产品的参与者。

讨论

本研究复制了先前的发现,进一步证明了使用体重控制产品与随后被诊断为 ED 之间存在前瞻性关联。

相似文献

引用本文的文献

本文引用的文献

7
9
Replication in Psychological Science.《心理科学中的复制》
Psychol Sci. 2015 Dec;26(12):1827-32. doi: 10.1177/0956797615616374. Epub 2015 Nov 9.
10
Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review.草药、膳食和减肥补充剂导致的肝损伤:综述。
J Clin Transl Hepatol. 2015 Jun 28;3(2):93-8. doi: 10.14218/JCTH.2015.00006. Epub 2015 Jun 15.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验